The Latest Cardiac and Vascular News
EMERYVILLE, Calif., May 4, 2022 /PRNewswire/ — Discovering new ways to treat heart and lung diseases by tapping into the natural disease resistance of hibernating animals is the focus of a new partnership between Monash University and Fauna Bio, a U.S. biotechnology company. Hibernation requires mechanisms of self-healing and tissue repair to endure […]
ST. PAUL, Minn., May 3, 2022 /PRNewswire/ — 3M™ Littmann® today announced its 3M™ Littmann® CORE Digital Stethoscope received honorable mention accolades in the health category of the 2022 Fast Company World Changing Ideas global awards program recognizing companies, products and initiatives that support innovation for the public good and tackle social inequality, climate change and public health […]
ANDOVER, Mass., May 3, 2022 /PRNewswire/ — TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today reported financial results for the quarter ended March 31, 2022. Recent Highlights Net revenue of $15.9 million in the first quarter of 2022, […]
ALAMEDA, Calif., May 3, 2022 /PRNewswire/ — Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today reported financial results for the first quarter ended March 31, 2022. Revenue of $203.9 million in the first quarter of 2022, an increase of 20.5%, or 21.8% in constant currency1, compared to the first quarter of […]
Initiated Next Phase of European Expansion Strategy with First National Reimbursement in Sweden Market Access Negotiations and Launch Preparations for VAZKEPA Underway Across Multiple European Markets Continued Progress on Go-To-Market Strategy in the US Plans for Regulatory Filings for Approval of VASCEPA® (icosapent ethyl) in Several Additional Countries in 2022 Company to […]
Denmark’s only robotic cardiac electrophysiology team is recognized for leading the world in treating the most heart rhythm patients using Stereotaxis’ advanced robotic technology ST. LOUIS, May 04, 2022 (GLOBE NEWSWIRE) — Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, celebrates the achievements of the […]
PARIS, May 04, 2022 (GLOBE NEWSWIRE) — Quantum Genomics (Euronext Growth : ALQGC, OTCQX : QNNTF), a biopharmaceutical company specializing in the development of a new drug class directly targeting the brain to treat difficult-to-treat/resistant hypertension and heart failure, announces it is strengthening its leadership team with the appointment of Sarah Merlen-Boulenger as Head […]
LONDON–(BUSINESS WIRE)–LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today reported results for the quarter ended March 31, 2022. Financial Summary and Highlights1 Worldwide sales were $240.2 million, a decrease of 3.0 percent on a reported basis and 0.3 percent on a constant-currency basis, as compared to […]
PARIS–(BUSINESS WIRE)–Regulatory News: ACTICOR BIOTECH (ISIN : FR0014005OJ5 – ALACT) (Paris:ALACT), a clinical stage biopharmaceutical company dedicated to the development of innovative treatments for cardiovascular emergencies, today discloses the total number of voting rights and shares as of April 30, 2022 (pursuant to Article L. 233-8 II of the French […]
First Quarter 2022 Highlights Revenue was $304 million; GAAP net income per diluted share was $0.81; and Non-GAAP net income per diluted share was $0.93. IRVINE, Calif.–(BUSINESS WIRE)–Masimo (Nasdaq: MASI) today announced its financial results for the first quarter of 2022, ended April 2, 2022. First Quarter 2022 Results Revenue […]
